Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty

Part of paid clinical trials in Portland, Oregon.

Sponsor
Ortho Development Corporation
Study ID
NCT04277416
Status
Enrolling By Invitation

Conditions

  • Total Hip Arthroplasty
  • Total Hip Replacement

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Total Hip Arthroplasty — DEVICE
    To evaluate Implant survival based on removal or intended removal of any component of the Entrada™ Hip System at five years of follow-up.

Study Details

To evaluate Implant survival based on removal or intended removal of any component of the Entrada™ Hip System at five years of follow-up.

Key Dates

Start date
Feb 28, 2020
Status verified
Oct 2022
Primary completion
Dec 31, 2031
Completion
Dec 31, 2032

Study Design

Enrollment
250 participants (estimated)

Arms

  • Arm: Entrada Hip System
    All orthopaedic patients that are scheduled to undergo primary total hip arthroplasty using the Entrada™ Hip System within 12 weeks will be screened for the following eligibility criteria.

Primary Outcome Measure

Implant Survival [ Time Frame: 5 - 10-year follow-up ]

Locations (1)

FacilityCityStateZIPSite coordinators
Oregon Health Sciences UniversityPortlandOregon97239-

Find similar trials in Portland, OR

By research site
Oregon Health Sciences University· Portland, OR

Related Studies